Brachytherapy Afterloaders Market – Insights
In brachytherapy, a closed radiation source is positioned directly into or next to area that requires treatment. The radiotherapy is used for the treatment of various types of cancer such as breast, cervical, skin, and prostate cancer. A high energy X-ray is generated by the source and guided from outside the body with the help of radiation system in a normal External Beam Radiation Therapy (EBRT). The rays are focused on the tumor. In brachytherapy, a radioactive material is directly placed inside the tumor or next to it. Brachytherapy focuses on treatment of a particular area around the radiation source. This in turn helps to reduce exposure of radiation on healthy tissues.
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/1952
Brachytherapy reduces the chances of surviving cancer cells to grow and divide in the long intervals between each radiotherapy session. There are two types of brachytherapy afterloaders that include: low dose rate (LDR) afterloader and high dose rate (HDR) afterloader.
Increasing prevalence of cancer to augment the market growth
High incidence of cancer is a prime factor boosting growth of the global brachytherapy afterloaders market. For instance, according to the World Health Organization (WHO) 2018 report, cancer was the second-leading cause of death around the globe and was responsible for around 8.8 million death in 2015. Globally, around 1 out of 6 deaths is due to cancer. According to the same report, most common causes of cancer death was lung cancer with around 1.69 million deaths followed by liver cancer with 788,000 deaths, colorectal 774,000 deaths, stomach 754,000 deaths, and breast cancer having 571,000 deaths.
Increasing geriatric population is also expected to boost the market growth as this group is more vulnerable to cancer. For instance, according to United Nation 2017 report, the geriatric population in 2017 is expected to increase over double by 2050 and to over triple by 2100. These figures are expected to rise from 962 million globally in 2017 to 2.1 billion in 2050 and 3.1 billion in 2100.
Furthermore, high adoption of brachytherapy is contributing to growth of the market. For instance, in 2017, iCAD Inc. introduced Xoft electronic brachytherapy system at two of its California-based oncology centers – Sherman Oaks Radiation Therapy Center and Santa Clarita Radiation Therapy Center.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1952
North America is expected to account for the largest market share
The market in North America is expected to account for the largest market share over the forecast period. This is attributed to increasing investment in R&D in cancer treatment. For instance, in 2013, Varian Medical Systems, Inc. awarded US$ 100,000, a second year renewal grant to The American Board of Radiology Foundation (ABRF) for brachytherapy research.
Increasing geriatric population vulnerable to various cancer and related diseases and surge in healthcare expenditure is expected to boost growth of the market in Asia Pacific. For instance, according to United Nations 2017 report, in Asia, 12% of the population is already aged 60 years and the proportion is projected to reach 24% in 2050.
Major players in the market are focused on adopting (M&A) strategies to expand their product portfolio. For instance, in April 2018, Proton Partners International Ltd. acquired Elekta MR-linac systems to provide cancer patients with the most advanced treatment across U.K.
Major players operating in the global brachytherapy afterloaders market include, Elekta, Eckert & Zieglar BEBIG, and Varian Medical Systems, Inc.
To get detailed table of content (ToC), please click: https://www.coherentmarketinsights.com/ongoing-insight/toc/1952
Brachytherapy Afterloaders Market – Taxonomy
On the basis of technique, the global brachytherapy afterloaders market is segmented into:
- Low Dose Rate (LDR) Afterloaders
- High Dose Rate (HDR) Afterloaders
On the basis of application, the global brachytherapy afterloaders market is segmented into:
- Prostate Cancer
- Breast Cancer
- Cervical Cancer
On the basis of region, the global brachytherapy afterloaders market is segmented into:
- North America
- Latin America
- Asia Pacific
- Middle East
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027